Journey Medical Corp (DERM)
4.10 -0.06 (-1.44%) 11:20 ET [NASDAQ]
4.10 x 500 4.22 x 200
Realtime by (Cboe BZX)
4.10 x 500 4.22 x 200
Realtime 4.17 +0.01 (+0.24%) 08:48 ET
for Mon, Jan 27th, 2025
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Sales | 42,339 | 4,541 | 22,585 | 7,300 | 7,300 |
Cost of Goods | 1,176 | N/A | N/A | N/A | N/A |
Gross Profit | 41,163 | 4,541 | 22,585 | 7,300 | 7,300 |
Operating Expenses | 255,321 | 304,867 | 113,209 | 86,946 | 38,998 |
Operating Income | -213,982 | -300,326 | -90,624 | -79,646 | -31,698 |
Interest Expense | 15,639 | 8,140 | 0 | 147 | 153 |
Other Income | 7,887 | 5,205 | 1,540 | 772 | 7 |
Pre-tax Income | -221,734 | -303,261 | -89,084 | -79,021 | -31,844 |
Income Tax | -194 | N/A | N/A | -622 | 31 |
Net Income Continuous | -221,540 | -303,261 | -89,084 | -78,399 | -31,875 |
Net Income | $-221,540 | $-303,261 | $-89,084 | $-78,399 | $-31,875 |
EPS Basic Total Ops | -5.27 | -7.48 | -2.70 | -2.93 | -4.96 |
EPS Basic Continuous Ops | -5.27 | -7.48 | -2.70 | -2.93 | -4.96 |
EPS Diluted Total Ops | -5.27 | -7.48 | -2.70 | -2.93 | -4.96 |
EPS Diluted Continuous Ops | -5.27 | -7.48 | -2.70 | -2.93 | -4.96 |
EPS Diluted Before Non-Recurring Items | -5.24 | -4.39 | -2.70 | -2.87 | -4.96 |
EBITDA(a) | $-213,902 | $-297,621 | $-88,622 | $-77,562 | $-31,444 |